SEARCH

SEARCH BY CITATION

References

  • Alijagic, S., Müller, P., Artuc, M., Jurgovsky, K., Czarnetzki, B. M. and Schadendorf, D., Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T-cell activation. Europ. J. Immunol., 25, 31003107 (1995).
  • Bakker, A. B., Schreurs, M. W. J., Deboer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. and Figdor, C. G., Melanocyte-lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. exp. Med., 179, 10051009 (1994).
  • Bender, A., Bui, L. K., Feldman, M. A. V., Larsson, M. and Bhardwaj, N., Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T-cell responses. J. exp. Med., 182, 16631671 (1995).
  • Bodmer, H., Ogg, G., Gotch, F. and McMichael, A., Anti-HLA-A2-antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342, 443446 (1989).
  • Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., Deplaen, E., Lethe, B., Coulie, P. and Boon, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489495 (1993).
  • Caux, C., Dezutter-Dambuyant, C. and Schmitt, D., GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360, 258261 (1992).
  • Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., Deplaen, E., Lurquin, C., Szikora, J.-P., Renauld, J.-C. and Boon, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 3542 (1994).
  • Coulie, P. G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M. and Boon, T., A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. nat. Acad. Sci. (Wash.), 92, 79767980 (1995).
  • Dranoff, G., Jaffee, E., Lazenbry, A., Golumbek, P., Levitsky, H., Brose, K., Jeckson, V., Hamada, H., Pardoll, D. and Mulligan, R., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage-colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 35393543 (1993).
  • Jäger, E., Bernhard, H., Romero, P., Ringhoffer, M., Arand, M., Karbach, J., Ilsemann, C., Hagedorn, M. and Knuth, A., Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer, 66, 162169 (1996a).
  • Jäger, E., Ringhoffer, M., Karbach, J., Arand, M., Oesch, F. and Knuth, A., Inverse relationship of melanocyte-differention-antigen expression in melanoma: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer, 66, 470476 (1996b).
  • Kang, X. Q., Kawakami, Y., El-Gamil, M., Wang, R., Sakaguchi, K., Yannelli, J. R., Appella, E. and Rosenberg, S. A., Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol., 155, 13431348 (1995).
  • Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T. and Rosenberg, S. A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 35253519 (1994a).
  • Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. and Rosenberg, S. A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 64586462 (1994b).
  • Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X. Q., Southwood, S., Robbins, P. F., Sette, A., Appella, E. and Rosenberg, S. A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with in vivo tumor regression. J. Immunol., 154, 39613968 (1995).
  • Knuth, A., Wölfel, T. and Meyer Zum Büschenfelde, K.-H., T-cell responses to human malignant tumours. Cancer Surveys, 13, 3952 (1992).
  • Kovacsovics-Bankowski, M. and Rock, K. L., A phagosome-to-cytosol pathway for exogenous antigens presented on MHC-class-I molecules. Science, 267, 243246 (1995).
  • Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M. and Eisenbach, L., CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.), 369, 6771 (1994).
  • Marchand, M. and 20 others, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883885 (1995).
  • Matzinger, P., Tolerance, danger, and the extended family. Ann. Rev. Immunol., 12, 9911045 (1994).
  • Noguchi, Y., Richards, E. C., Chen, Y. T. and Old, L. J., Influence of interleukin-12 on p53-peptide vaccination against established Meth A sarcoma. Proc. nat. Acad. Sci. (Wash.), 92, 22192223 (1995).
  • Norbury, C. C., Hewlett, L. J., Prescott, A. R., Shastri, N. and Watts, C., Class-I-MHC presentation of exogenous soluble antigen via macropinocytosis in bone-marrow macrophages. Immunity, 3, 783791 (1995).
  • Robbins, P. F., El-Gamil, M., Kawakami, Y. and Rosenberg, S. A., Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54, 31243126 (1994).
  • Schirmbeck, R., Melber, K. and Reimann, J., Hepatitis-B-virus small-surface antigen particles are processed in a novel endosomal pathway for major-histocompatibility-complex-class-I-restricted epitope presentation. Europ. J. Immunol., 25, 10631070 (1995).
  • Sternberger, L., Immunocytochemistry, 2nd ed., pp. 104168, John Wiley, New York, Chichester, Brisbane, Toronto (1979).
  • Van Der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van Den Eynde, B., Knuth, A. and Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 16431647 (1991).
  • Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., Deplaen, E., Hankeln, T., Meyer Zum Büschenfelde, K.-H. and Beach, D., A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 12811284 (1995).
  • Wölfel, T., Schneider, J., Meyer Zum Büschenfelde, K.-H., Rammensee, H.-G., Rötzschke, O. and Falk, K., Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer, 57, 413418 (1994).